semaglutide and liver issues Metabolic dysfunction-associated steatotic disease (MASLD) affects nearly one in three adults worldwide, yet many cases remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? Semaglutide (Ozempic/Wegovy) dramatically improves fatty

A 2023 analysis of GLP-1 users across diverse hormone profiles found that estrogen status did not meaningfully alter semaglutide efficacy or adverse event rates

Ongoing medical weight loss management is handled separately from surgery

Tirzepatide produces greater average weight loss, so its additional GIP activity is considered an important part of its advantage

Your provider can assess whether dose titration, formulation change, or temporary pause would optimize your safety and tolerability profile

The novel findings generate new hypotheses regarding serine-folate-glycine one carbon and serine-phospholipid metabolism, elevation of end products of catabolic pathways, shifts in folate, thiamine and other vitamins with exercise, and changes in sphingomyelins that may indicate myelin and white matter dysfunction in ME/CFS